Zacks Investment Research
11 May 2026, 23:01 UTC · 25w ago
Verdict
Headline takes no side. We score HCAT +0.40 across three claims — moderately bullish.
+0.40moderately bullish
More positive than 63% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
What the story claims
3 claims · scored −1 bearish … +1 bullish
Health Catalyst (HCAT) reported a 300% positive EPS surprise for the quarter ended March 2026, with $0.02 compared to the $0.01 estimate.
More positive than 76% of claims this week
Health Catalyst reported revenue of $70.76 million, which is a 10.9% decrease compared to the same period last year.
So whatDouble-digit year-over-year revenue decline suggests shrinking organic growth or loss of market share.
Continue reading
5 related stories
More negative than 78% of claims this week
Health Catalyst's quarterly revenue of $70.76 million slightly beat the Zacks Consensus Estimate of $69.34 million by 2.04%.
So whatA marginal beat on the top line is a mildly positive signal but is overshadowed by the year-over-year decline.
More positive than 40% of claims this week
Which stocks this story touches
More positive than 63% of ticker scores this week
The company reported a revenue and EPS surprise above Zacks Consensus Estimates, although year-over-year revenue declined.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
18m ago
+8.7%
Price agrees with the score
$1.50 vs $1.38 close before publication (May 11) · not market-adjusted
HCAT chart →
